Compare StocksGEHC vs JNJ

GE HealthCare Technologies Inc. (GEHC) vs Johnson & Johnson (JNJ): Which Is the Better Buy in 2026?

As of 2026-06-19, GEHC is undervalued at $62, with a DCF intrinsic value of $100 and a margin of safety of 38%. JNJ is fairly valued at $228, with an intrinsic value of $281 and a margin of safety of 19%. Of the two, GEHC has the wider margin of safety.

GEHC
GE HealthCare Technologies Inc.
$61.59
VS
JNJ
Johnson & Johnson
$228.39

Rewards

GEHC
  • GE HealthCare Technologies Inc. scores 93/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Return on equity has consistently exceeded 20% over 4 years, indicating efficient use of shareholder capital.
  • 8 insider purchases totaling $6.4M with no sells in the past 3 months — insiders are putting their own money in.
JNJ
  • Johnson & Johnson has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Gross margin of 68.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Johnson & Johnson scores 90/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.

Risks

GEHC
  • FCF yield of 5.3% suggests reasonable valuation assuming continued moderate growth.
  • Free cash flow has declined at a 5.8% CAGR over the past 4 years — a concerning trend.
JNJ
  • Trailing P/E of 26.5x is 33% above the historical average of 20.0x — the stock trades at a premium to its own history.
  • PEG ratio of 3.06 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Insiders have sold $2.4M worth of stock in the past 3 months — significant insider liquidation.

Key Valuation Metrics

Learn more →
GEHC
JNJ
Valuation
$1.48B
Free Cash Flow
$19.31B
5.30%
FCF Yield
3.51%
14.77
Trailing P/E
26.46
11.48
Forward P/E
17.96
Quality & Moat
8.56%
ROIC
15.32%
19.46%
ROE
26.42%
39.14%
Gross Margin
68.04%
1.79
PEG Ratio
3.06
Balance Sheet Safety
0.76
Net Debt / Equity
0.41
N/A
Interest Coverage
N/A
2.36
Net Debt / EBITDA
0.96
0.23%
Dividend Yield
2.22%
GEHC: 4Ties: 1JNJ: 7
GEHCJNJ

Historical Fundamentals

Learn more →
GEHC

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

JNJ

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
GEHC
$1.98
created per $1 retained over 3 years
Value Creator
Σ Retained
$5.49B
Δ Market Cap
+$10.87B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
JNJ
$0.91
created per $1 retained over 3 years
Mediocre Allocator
Σ Retained
$40.05B
Δ Market Cap
+$36.63B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
GEHC
38.2% Margin of Safety
Price is 38.2% below estimated fair value
Current Price: $61.59
Fair Value: $99.71
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
JNJ
18.6% Margin of Safety
Price is 18.6% below estimated fair value
Current Price: $228.39
Fair Value: $280.51
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
GEHC

What growth rate is the market pricing in at $62?

+5.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +10.5%

The market implies +5.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +10.5%, reflecting heavy growth investment.

JNJ

What growth rate is the market pricing in at $228?

+7.7%
Market-Implied Owner Earnings Growth
Standard FCF implies +13.3%

The market implies +7.7% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +13.3%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
GEHC
93/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
JNJ
90/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
GEHC
-2.36
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
JNJ
-2.31
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
GEHC
Insiders 0.4%Institutions 93.9%Retail & Other 5.8%
No. of Institutional Holders1,753
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
JNJ
Insiders 0.1%Institutions 76.9%Retail & Other 23.1%
No. of Institutional Holders5,728
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
GEHC
8
Buys (3M)
8
Buys (12M)
Total value (12M): $6.42M
LOBO KEVIN A
Director
$641,800
@ $64.18 · 2026-05-22
HOCHMAN RODNEY F
Director
$100,365
@ $62.03 · 2026-05-12
YANG WATKIN PHOEBE L
Director
$63,006
@ $63.01 · 2026-05-08
CULP HENRY LAWRENCE JR.
Director
$5.00M
@ $61.88 · 2026-05-06
STROMBERG WILLIAM J
Director
$61,689
@ $61.69 · 2026-05-06
SACCARO JAMES
Chief Financial Officer
$200,585
@ $60.60 · 2026-05-01
ARDUINI PETER J
Chief Executive Officer
$249,827
@ $59.92 · 2026-04-30
JIMENEZ FRANK R
General Counsel
$105,788
@ $60.45 · 2026-04-30
Open market purchases · includes direct & indirect ownership · excludes option exercises
JNJ
0
Buys (3M)
1
Buys (12M)
Total value (12M): $257,688
MORIKIS JOHN G
Director
$257,688
@ $206.15 · 2025-11-26
WEINBERGER MARK A
Director
$147,220
@ $147.22 · 2024-12-12
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
GEHC
0
Sells (3M)
0
Sells (12M)
NEWCOMB GEORGE A.
Officer
$185,080
@ $92.54 · 2025-02-18
ROTT ROLAND
Officer
$309,339
@ $86.48 · 2024-11-06
RACKLIFFE PHILIP
Chief Executive Officer
$78,867
@ $87.63 · 2024-11-05
STACHERSKI KENNETH ROBERT
Officer
$1.58M
@ $83.22 · 2024-08-14
WESTRICK THOMAS J
Officer
$222,145
@ $80.78 · 2024-08-07
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
JNJ
1
Sells (3M)
13
Sells (12M)
Total value (12M): $103.65M
WENGEL KATHRYN E
Chief Technology Officer
$2.41M
@ $241.15 · 2026-06-11
DECKER ROBERT J
Officer
$1.01M
@ $247.87 · 2026-02-27
SCHMID TIMOTHY
Officer
$324,763
@ $245.66 · 2026-02-20
SCHMID TIMOTHY
Officer
$5.53M
@ $244.33 · 2026-02-18
SWANSON JAMES D
Chief Technology Officer
$15.11M
@ $243.39 · 2026-02-17
BROADHURST VANESSA
Officer
$1.51M
@ $243.39 · 2026-02-17
WOLK JOSEPH J
Chief Financial Officer
$21.77M
@ $242.80 · 2026-02-17
REED JOHN C
Officer
$13.11M
@ $243.00 · 2026-02-17
REED JOHN C
Officer
$4.19M
@ $192.71 · 2025-10-17
TAUBERT JENNIFER L
Officer
$10.04M
@ $177.81 · 2025-09-04
DUATO JOAQUIN BOIX
Chief Executive Officer
$22.55M
@ $179.21 · 2025-08-22
WOLK JOSEPH J
Chief Financial Officer
$2.98M
@ $176.91 · 2025-08-15
REED JOHN C
Officer
$3.13M
@ $163.55 · 2025-07-17
DECKER ROBERT J
Officer
$1.16M
@ $165.88 · 2025-02-25
SCHMID TIMOTHY
Officer
$62,928
@ $156.15 · 2025-02-18
WOLK JOSEPH J
Chief Financial Officer
$2.00M
@ $153.89 · 2025-02-07
DECKER ROBERT J
Officer
$930,113
@ $165.06 · 2024-08-30
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
GEHC
FearGreed
😨Fear(37/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
JNJ
FearGreed
😏Greed(62/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
GEHC
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (37)
JNJ
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (62)
View GEHC Full AnalysisView JNJ Full Analysis

Frequently Asked Questions: GEHC vs JNJ

Is GE HealthCare Technologies Inc. or Johnson & Johnson more undervalued in 2026?

Based on our discounted cash flow model, GEHC trades at a 38.2% margin of safety (intrinsic value $100 vs. price $62), compared to JNJ's 18.6% margin of safety (intrinsic $281 vs. $228).

Which stock has a wider economic moat, GE HealthCare Technologies Inc. or Johnson & Johnson?

GEHC scores 93/100 (Wide moat), while JNJ scores 90/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is GE HealthCare Technologies Inc. in financial distress?

GEHC's Altman Z-Score of 2.0 places it in the Grey zone, signaling elevated bankruptcy risk. JNJ scores 3.5 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, GE HealthCare Technologies Inc. or Johnson & Johnson?

GE HealthCare Technologies Inc. (GEHC) generates a 5.3% free cash flow yield, compared to Johnson & Johnson's 3.5%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, GE HealthCare Technologies Inc. or Johnson & Johnson?

JNJ earns 15.3% ROIC versus GEHC's 8.6%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, GE HealthCare Technologies Inc.'s or Johnson & Johnson's?

GEHC's dividend earns a safety score of 91/100 (Very Safe), compared to JNJ's 79/100 (Safe). GEHC has raised its dividend for 2 consecutive years.

GEHC vs JNJ: Which Is the Better Buy in 2026? | SafetyMargin.io